BOTOX® Cosmetic helps lessen the appearance of moderate to severe crow’s feet lines and glabellar lines. The images below show a “before and after” treatment
BOTOX® Cosmetic helps lessen the appearance of moderate to severe crow’s feet lines and glabellar lines. The images below show a “before and after” treatment
BOTOX® Cosmetic was initially approved in 2002 for the temporary improvement of moderate to severe glabellar lines (frown lines between the brows) for adult patients.
BOTOX® Cosmetic is the number-one prescribed product of its kind in the world with more than 11 million procedures performed to date. BOTOX® Cosmetic has been approved in 75 countries for aesthetic use.
On September 11, 2013 BOTOX® Cosmetic was approved by the U.S. Food and Drug Administration (FDA) for an additional indication to temporarily improve the appearance of moderate to severe lateral canthal lines, commonly known as “crow’s feet” lines in adults. It is the first and only product of its kind approved for this indication.
BOTOX® Cosmetic is the only FDA-approved treatment option for both crow’s feet lines and glabellar lines.
BOTOX® Cosmetic works by temporarily blocking nerve impulses and reducing movement to the muscles around the eye area and forehead. The decreased muscle activity helps lessen the appearance of moderate to severe crow’s feet lines and glabellar lines for results that do not radically change facial appearance or make a patient look as if they have had “work done.”
BOTOX® Cosmetic is a prescription medication that produces noticeable, yet subtle results, without surgery or recovery time. It is a quick, 10- minute, minimally invasive treatment that is often referred to as a “lunch-time” procedure.
It is important that BOTOX® Cosmetic be administered by a licensed, trained healthcare professional.